Active Music-Based Intervention in Patients With Chronic Low Back Pain
Does Active Music-Based Intervention Alter Cognitive Function, Sensitivity to Stimuli, Pain Catastrophizing and Quality of Life in Patients With Chronic Low Back Pain?
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn if active music-based intervention works to treat patients with chronic low back pain. The main questions it aims to answer are:
- 1.Does active music-based intervention improve cognitive function?
- 2.Does active music -based intervention improve sensitivity to stimuli?
- 3.Does active music-based intervention improve pain catastrophizing behavior?
- 4.Does active music-based intervention improve quality of life?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2025
CompletedFirst Posted
Study publicly available on registry
April 23, 2025
CompletedStudy Start
First participant enrolled
August 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
January 9, 2026
January 1, 2026
1.6 years
April 2, 2025
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive function
Cognitive function will be assessed using the Stroop Color and Word Test (SCWT). The SCWT is used to measure a person's attentional interference or the ability to inhibit the interference of a second stimulus while continuing to process an original stimulus. A computerized version of the SCWT via a software program DirectRT (Empirisoft Corp., New York, NY) will be used. The SCWT consists of 3 parts, each containing 24 consecutive stimuli. A reaction time will be computed in software based on the speed of the participant's response.
This outcome measure (SCWT) will be administered twice, before the start of treatment and after the end of treatment at 2 weeks.
Cognitive function
Cognitive function will be assessed using the Comprehensive Trail Making Test - Second Edition (CTMT2). The CTMT2 consists of 5 trails requiring cognitive control between competing stimuli and schemas. Trails 1-3 measure inhibitory control by completing trails with increasing numbers of distractors. Trails 4-5 measure set-shifting by requiring participants to shift between opposing mental sets (i.e., numbers and letters). The test will use standardized instructions.
This outcome measure (CTMT2) will be administered twice, before the start of treatment and after the end of treatment at 2 weeks.
Secondary Outcomes (3)
Sensitivity to stimuli
This outcome measure (PPT) will be administered twice, before the start of treatment and after the end of treatment at 2 weeks.
Pain catastrophizing
This outcome measure (PCS) will be administered twice, before the start of treatment and after the end of treatment at 2 weeks.
Health-related Quality of life
This outcome measure (PROMIS-29) will be administered twice, before the start of treatment and after the end of treatment at 2 weeks.
Study Arms (1)
Active music-based in tervention
EXPERIMENTALActive musical interventions include playing an instrument, singing, or songwriting.
Interventions
Musical experience includes playing an instrument, singing, or songwriting.
Eligibility Criteria
You may qualify if:
- adults 18-65 years of age
- have chronic low back pain (CLBP) primarily in the L4-5 area. The CLBP is defined as a back pain problem that has persisted at least 3 months and has resulted in pain on at least half the days in the past 6 months.
You may not qualify if:
- Participants will be excluded if their low back pain (LBP) is due to a non-musculoskeletal origin or they have any medical conditions that may affect the results:
- Previous back surgery
- Systemic arthritis (e.g., rheumatoid arthritis, psoriatic arthritis).
- Fracture of thoracic and lumbar spine, pelvis
- Infection
- Tumor
- Traumatic brain injury
- Stroke
- Seizures/epilepsy
- Any other neurological disease (e.g., multiple sclerosis, muscular dystrophy, - Parkinson's)
- Circulation/vascular problems (e.g., Raynaud's)
- Cancer
- Uncontrolled diabetes/high blood sugar
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Texas Woman's Universitycollaborator
- Sharon Wang-Pricelead
Study Sites (1)
Texas Woman's University, Department of Music
Denton, Texas, 76204, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon Wang-Price, PhD
Texas Woman's University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor/Faculty
Study Record Dates
First Submitted
April 2, 2025
First Posted
April 23, 2025
Study Start
August 7, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Sharing IPD raises ethical concerns about participant privacy and the potential for misuse of sensitivity data. Data protection laws and regulations can restrict the sharing of personal data, even for research purposes.